ArticleDusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi2025
Differences in clozapine metabolism across geographical regions in Turkiye.
Article in Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The efficacy of clozapine is influenced by the pharmacogenetics of its metabolism, which can vary significantly among individuals. This study investigates regional variations in serum clozapine and norclozapine levels across Turkiye. Method: A retrospective analysis was conducted on 1,428 serum clozapine measurements from 328 patients treated at Hacettepe University Department of Psychiatry between 2014 and 2022. Patients were categorized based on their birthplaces and residential addresses into seven geographical regions of Turkiye. Serum levels of clozapine and norclozapine were measured, and clozapine/norclozapine ratios were calculated. Linear mixed models were used to assess the effects of region, age, sex, and clozapine dose on therapeutic drug monitoring outcomes. Results: Significant regional differences were observed in serum norclozapine levels, with notably lower levels in the Eastern Anatolia Region (β=-179.04, SE=49.7). No significant regional differences were found in serum clozapine levels or clozapine/ norclozapine ratios. Age (p=0.004) and clozapine dose (p<0.001) were positively associated with norclozapine levels, while sex showed no significant association. Conclusion: This study highlights inter-regional differences in clozapine metabolism within Turkiye, suggesting that regional factors may play a role in clozapine pharmacokinetics. These findings indicate that clozapine metabolism is influenced not only by genetic variability but also by a complex relationship of sociocultural factors. The results support the need for more personalized approaches to clozapine dosing and monitoring to enhance treatment efficacy, safety, and tolerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.